iShares US Medical Devices ETF

IHI

Valor de mercado US$ 3,73 bi

BOSTON--(BUSINESS WIRE)--IHI today announced the appointment of Amar Shah, MBBS, FRCPsych, LLM, MA, MBA, MBE, as permanent Chief Scientific Officer (CSO).

Looking for broad exposure to the Healthcare - Medical Devices segment of the equity market? You should consider the iShares U.S. Medical Devices ETF (IHI), a passively managed exchange traded fund launched on May 1, 2006.

iShares U.S. Medical Devices ETF is rated a sell due to historical underperformance, high concentration risk, and elevated valuation. IHI's top three holdings—ABT, ISRG, SYK—comprise nearly 43% of the portfolio, amplifying downside risk if growth falters or valuations compress. The ETF's 34x PE and sub-0.5% yield create an unattractive risk-reward profile, especially given its 18–20% volatility and minimal income.

Launched on May 1, 2006, the iShares U.S. Medical Devices ETF (IHI) is a passively managed exchange traded fund designed to provide a broad exposure to the Healthcare - Medical Devices segment of the equity market.

I reiterate a Hold rating on the iShares US Medical Devices ETF despite its 20% YTD decline and ongoing technical weakness. IHI's valuation is reasonable but not compelling, with a P/E of 18.8x and a 10.3% long-term EPS growth rate. The ETF is highly concentrated, with its top 10 holdings accounting for 75% of the portfolio and a low dividend yield at 0.45%.

ETFs like XLV stand out as aging U.S. demographics fuel rising demand for healthcare, medical devices and senior-focused care.

ANN ARBOR, MI / ACCESS Newswire / May 6, 2026 / Dynamic Aerospace Systems Corporation (OTCQB:BRQL), a U.S.-based manufacturer of unmanned aerial systems (UAS), announced it will host a Japanese defense and industrial delegation on May 15, 2026, at its Ann Arbor facility to evaluate its drone platforms in live operational demonstrations. The delegation includes representatives from major defense and industrial organizations, including the Japan Defense Technology Foundation, Mitsubishi Heavy Industries, Ltd.

Investors are questioning the staying power of medical technology (medtech) stocks, which have fallen from grace since the COVID-19 pandemic. The starting point is to distinguish between medtech and other healthcare industries.

Launched on May 1, 2006, the iShares U.S. Medical Devices ETF (IHI) is a passively managed exchange traded fund designed to provide a broad exposure to the Healthcare - Medical Devices segment of the equity market.

I rate iShares US Medical Devices ETF a buy, as its recent selloff offers an attractive entry into industry-leading medical device innovators. IHI's top holdings—Abbott Laboratories, Intuitive Surgical, and Boston Scientific—drive growth through strong fundamentals, product innovation, and exposure to secular healthcare trends. Despite higher fees (0.38%) and volatility, IHI's concentrated exposure to medical devices positions it for long-term capital appreciation over more diversified healthcare ETFs.